280
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Prevalence of Sarcopenia in Africa: A Systematic Review

ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon
Pages 1021-1035 | Received 09 Feb 2023, Accepted 27 Jun 2023, Published online: 04 Jul 2023

References

  • Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169
  • 2023 ICD-10-CM diagnosis code M62.84: sarcopenia. Available from: https://www.icd10data.com/ICD10CM/Codes/M00-M99/M60-M63/M62-/M62.84. Accessed October 21, 2022.
  • Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-9
  • Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc. 2013;61(6):974–980. doi:10.1111/jgs.12260
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
  • Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36. doi:10.1002/jcsm.12048
  • Ishii S, Tanaka T, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int. 2014;14 Suppl 1:93–101. doi:10.1111/ggi.12197
  • Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:10.1016/j.jamda.2019.12.012
  • Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. current consensus definition: prevalence, etiology, and consequences. international working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–256. doi:10.1016/j.jamda.2011.01.003
  • Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol. 2014;69(5):547–558. doi:10.1093/gerona/glu010
  • Kruger HS, Micklesfield LK, Wright HH, Havemann-Nel L, Goedecke JH. Ethnic-specific cut-points for sarcopenia: evidence from black South African women. Eur J Clin Nutr. 2015;69(7):843–849. doi:10.1038/ejcn.2014.279
  • Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019;48(1):48–56. doi:10.1093/ageing/afy106
  • Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16(1). doi:10.1186/s40200-017-0302-x
  • da AT, Duarte de S, Santos JLF, Lebrão ML. Prevalence and associated factors of sarcopenia, dynapenia, and sarcodynapenia in community-dwelling elderly in São Paulo - SABE study. Rev Bras Epidemiol Braz J Epidemiol. 2019;21(Suppl 02):e180009. doi:10.1590/1980-549720180009.supl.2
  • Patel HP, Syddall HE, Jameson K, et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing. 2013;42(3):378–384. doi:10.1093/ageing/afs197
  • Ren X, Zhang X, He Q, et al. Prevalence of sarcopenia in Chinese community-dwelling elderly: a systematic review. BMC Public Health. 2022;22(1):1702. doi:10.1186/s12889-022-13909-z
  • The BMJ. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. Available from: https://www.bmj.com/content/372/bmj.n160. Accessed October 21, 2022.
  • Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–939. doi:10.1016/j.jclinepi.2011.11.014
  • Dlamini SN, Norris SA, Mendham AE, et al. Targeted proteomics of appendicular skeletal muscle mass and handgrip strength in black South Africans: a cross-sectional study. Sci Rep. 2022;12(1):9512. doi:10.1038/s41598-022-13548-9
  • Gregson CL, Madanhire T, Rehman A, et al. Osteoporosis, rather than sarcopenia, is the predominant musculoskeletal disease in a rural South African community where human immunodeficiency virus prevalence is high: a cross-sectional study. J Bone Miner Res off J Am Soc Bone Miner Res. 2022;37(2):244–255. doi:10.1002/jbmr.4464
  • Irwin NEA, Fabian J, Hari KR, Lorentz L, Mahomed A, Botha JF. Myosteatosis, the more significant predictor of outcome: an analysis of the impact of myosteatosis, sarcopenia, and sarcopenic obesity on liver transplant outcomes in Johannesburg, South Africa. Exp Clin Transplant off J Middle East Soc Organ Transplant. 2021;19(9):948–955. doi:10.6002/ect.2021.0083
  • Pina I, Mendham AE, Tomaz SA, et al. Intensity matters for musculoskeletal health: a cross-sectional study on movement behaviors of older adults from high-income Scottish and low-income South African Communities. Int J Environ Res Public Health. 2021;18(8):4310. doi:10.3390/ijerph18084310
  • Mendham AE, Goedecke JH, Micklesfield LK, et al. Understanding factors associated with sarcopenic obesity in older African women from a low-income setting: a cross-sectional analysis. BMC Geriatr. 2021;21(1):247. doi:10.1186/s12877-021-02132-x
  • Essomba MJN, Atsa D, Noah DZ, et al. Geriatric syndromes in an urban elderly population in Cameroon: a focus on disability, sarcopenia and cognitive impairment. Pan Afr Med J. 2020;37:229. doi:10.11604/pamj.2020.37.229.26634
  • Laubscher CV, Burger MC, Conradie MM, Conradie M, Jordaan JD. Prevalence of sarcopenia in older South African patients following surgery for fragility fractures of the Hip. Geriatr Orthop Surg Rehabil. 2020;11:2151459320971560. doi:10.1177/2151459320971560
  • Salinas-Rodríguez A, Rivera-Almaraz A, Scott A, Manrique-Espinoza B. Severity levels of disability among older adults in low- and middle-income countries: results from the study on global ageing and adult health (SAGE). Front Med. 2020;7:562963. doi:10.3389/fmed.2020.562963
  • Kruger HS, Havemann-Nel L, Ravyse C, Moss SJ, Tieland M. Physical activity energy expenditure and sarcopenia in black South African urban women. J Phys Act Health. 2016;13(3):296–302. doi:10.1123/jpah.2015-0078
  • Ngeuleu A, Allali F, Medrare L, Madhi A, Rkain H, Hajjaj-Hassouni N. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatol Int. 2017;37(6):1015–1020. doi:10.1007/s00296-017-3665-x
  • Adebusoye LA, Ogunbode AM, Olowookere OO, Ajayi SA, Ladipo MM. Factors associated with sarcopenia among older patients attending a geriatric clinic in Nigeria. Niger J Clin Pract. 2018;21(4):443–450. doi:10.4314/njcp.v21i4
  • Zengin A, Jarjou LM, Prentice A, Cooper C, Ebeling PR, Ward KA. The prevalence of sarcopenia and relationships between muscle and bone in ageing West‐African Gambian men and women. J Cachexia Sarcopenia Muscle. 2018;9(5):920–928. doi:10.1002/jcsm.12341
  • Barnard SA, Pieters M, Nienaber-Rousseau C, Kruger HS. Degree of obesity influences the relationship of PAI-1 with body fat distribution and metabolic variables in African women. Thromb Res. 2016;146:95–102. doi:10.1016/j.thromres.2016.09.003
  • Essomba MJ, Noah D, Sylvain Raoul SN, Ashuntantang G. Facteurs associés à la sarcopénie chez des patients âgés de 55 Ans et plus dans un service de médecine interne au cameroun sarcopenia and associated factors in patients aged 55 and over in an i nternal medicine department in Cameroon. Health Sci Dis. 2022;23:58–61.
  • El Maghraoui A, Ebo’o FB, Sadni S, Majjad A, Hamza T, Mounach A. Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis? BMC Musculoskelet Disord. 2016;17:268. doi:10.1186/s12891-016-1155-z
  • B H, E MM, R A, A RA, A A, S A. Baseline sarcopenia is associated with lack of response to therapy, liver decompensation and high mortality in hepatocellular carcinoma patients. Asian Pac J Cancer Prev APJCP. 2020;21(11):3285–3290. doi:10.31557/APJCP.2020.21.11.3285
  • Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L, Moreno SG. Assessing publication bias in meta-analyses in the presence of between-study heterogeneity. JR Stat Soc Ser a Stat Soc. 2010;173(3):575–591. doi:10.1111/j.1467-985X.2009.00629.x
  • Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med. 2007;26(25):4544–4562. doi:10.1002/sim.2889
  • Choo YJ, Chang MC. Prevalence of sarcopenia among the elderly in Korea: a meta-analysis. J Prev Med Pub Health. 2021;54(2):96–102. doi:10.3961/jpmph.21.046
  • Diz JBM, Leopoldino AAO, de MB, et al. Prevalence of sarcopenia in older Brazilians: a systematic review and meta-analysis. Geriatr Gerontol Int. 2017;17(1):5–16. doi:10.1111/ggi.12720
  • Chen Z, Li WY, Ho M, Chau PH. The prevalence of sarcopenia in Chinese older adults: meta-analysis and meta-regression. Nutrients. 2021;13(5):1441. doi:10.3390/nu13051441
  • Bertschi D, Kiss CM, Beerli N, Kressig RW. Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines. Eur J Clin Nutr. 2021;75(4):653–660. doi:10.1038/s41430-020-00780-7
  • Papadopoulou SK, Tsintavis P, Potsaki P, Papandreou D. Differences in the prevalence of sarcopenia in community-dwelling, nursing home and hospitalized individuals. a systematic review and meta-analysis. J Nutr Health Aging. 2020;24(1):83–90. doi:10.1007/s12603-019-1267-x
  • Martone AM, Bianchi L, Abete P, et al. The incidence of sarcopenia among hospitalized older patients: results from the Glisten study. J Cachexia Sarcopenia Muscle. 2017;8(6):907–914. doi:10.1002/jcsm.12224
  • Shimokata H, Ando F, Yuki A, Otsuka R. Age-related changes in skeletal muscle mass among community-dwelling Japanese: a 12-year longitudinal study. Geriatr Gerontol Int. 2014;14 Suppl 1:85–92. doi:10.1111/ggi.12219
  • Makizako H, Nakai Y, Tomioka K, Taniguchi Y. Prevalence of sarcopenia defined using the Asia Working Group for Sarcopenia criteria in Japanese community-dwelling older adults: a systematic review and meta-analysis. Phys Ther Res. 2019;22(2):53–57. doi:10.1298/ptr.R0005
  • Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257–275. doi:10.1210/rp.57.1.257
  • Juul A, Skakkebaek NE. Androgens and the ageing male. Hum Reprod Update. 2002;8(5):423–433. doi:10.1093/humupd/8.5.423
  • Kowal P. Definition of an older person. Proposed working definition of an older person in Africa for the MDS Project. Available from: https://www.academia.edu/19489000/Definition_of_an_older_person_Proposed_working_definition_of_an_older_person_in_Africa_for_the_MDS_Project. Accessed November 14, 2022.
  • Saeki C, Takano K, Oikawa T, et al. Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC Musculoskelet Disord. 2019;20(1):615. doi:10.1186/s12891-019-2983-4
  • Trevisan C, Vetrano DL, Calvani R, Picca A, Welmer AK. Twelve-year sarcopenia trajectories in older adults: results from a population-based study. J Cachexia Sarcopenia Muscle. 2022;13(1):254–263. doi:10.1002/jcsm.12875
  • Bischoff-Ferrari HA, Orav JE, Kanis JA, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015;26(12):2793–2802. doi:10.1007/s00198-015-3194-y
  • Tromp AM, Pluijm SM, Smit JH, Deeg DJ, Bouter LM, Lips P. Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol. 2001;54(8):837–844. doi:10.1016/s0895-4356(01)00349-3
  • Chen F, Xu S, Wang Y, et al. Risk factors for sarcopenia in the elderly with type 2 diabetes mellitus and the effect of metformin. J Diabetes Res. 2020;2020:3950404. doi:10.1155/2020/3950404
  • Hwang J, Park S. Gender-specific risk factors and prevalence for sarcopenia among community-dwelling young-old adults. Int J Environ Res Public Health. 2022;19(12):7232. doi:10.3390/ijerph19127232
  • Chen X, Hou L, Zhang Y, Dong B. Analysis of the prevalence of sarcopenia and its risk factors in the elderly in the Chengdu community. J Nutr Health Aging. 2021;25(5):600–605. doi:10.1007/s12603-020-1559-1
  • Simsek H, Meseri R, Sahin S, et al. Prevalence of sarcopenia and related factors in community-dwelling elderly individuals. Saudi Med J. 2019;40(6):568–574. doi:10.15537/smj.2019.6.23917
  • Riviati N, Setiati S, Laksmi PW, Abdullah M. Factors related with handgrip strength in elderly patients. Acta Med Indones. 2017;49(3):215–219.
  • Beaudart C, Sanchez-Rodriguez D, Locquet M, Reginster JY, Lengelé L, Bruyère O. Malnutrition as a strong predictor of the onset of sarcopenia. Nutrients. 2019;11(12):2883. doi:10.3390/nu11122883
  • Shen Y, Chen J, Chen X, Hou L, Lin X, Yang M. Prevalence and associated factors of sarcopenia in nursing home residents: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20(1):5–13. doi:10.1016/j.jamda.2018.09.012
  • Chatzipetrou V, Bégin MJ, Hars M, Trombetti A. Sarcopenia in chronic kidney disease: a scoping review of prevalence, risk factors, association with outcomes, and treatment. Calcif Tissue Int. 2022;110(1):1–31. doi:10.1007/s00223-021-00898-1
  • Mithal A, Bonjour JP, Boonen S, et al. Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2013;24(5):1555–1566. doi:10.1007/s00198-012-2236-y
  • Clynes MA, Gregson CL, Bruyère O, Cooper C, Dennison EM. Osteosarcopenia: where osteoporosis and sarcopenia collide. Rheumatology. 2021;60(2):529–537. doi:10.1093/rheumatology/keaa755
  • Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513–537. doi:10.1038/s41574-018-0062-9
  • Dodds RM, Granic A, Davies K, Kirkwood TBL, Jagger C, Sayer AA. Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ Study. J Cachexia Sarcopenia Muscle. 2017;8(2):229–237. doi:10.1002/jcsm.12157
  • Darroch P, O’Brien WJ, Mazahery H, Wham C. Sarcopenia prevalence and risk factors among residents in aged care. Nutrients. 2022;14(9):1837. doi:10.3390/nu14091837
  • Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JWL. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas. 2015;82(4):418–423. doi:10.1016/j.maturitas.2015.08.006
  • Nair KS. Aging muscle. Am J Clin Nutr. 2005;81(5):953–963. doi:10.1093/ajcn/81.5.953
  • Mesinovic J, McMillan LB, Shore-Lorenti C, De Courten B, Ebeling PR, Scott D. Metabolic syndrome and its associations with components of sarcopenia in overweight and obese older adults. J Clin Med. 2019;8(2):145. doi:10.3390/jcm8020145